Abstract

Abstract If Global Health Impact labeling is successful, it will give companies a reason to produce drugs that will save millions of lives. One might wonder, however, whether consumers have any moral obligation to purchase goods from Global Health Impact–certified companies or whether purchasing these goods is even morally permissible. The fourth chapter suggests that, if the proposal is implemented, there is reason to purchase goods from Global Health Impact–certified companies. It defends something along the lines of this argument: (1) pharmaceutical companies violate rights and (2) do not do enough to address the access to medicines issue, so (3) if the Global Health Impact initiative helps rectify these problems, people should generally purchase goods from certified companies.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.